Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
Get Alerts CATB Hot Sheet
Join SI Premium – FREE
BOSTON--(BUSINESS WIRE)-- Catabasis Pharmaceuticals, Inc. (NASDAQ: CATB), a biopharmaceutical company, today announced that Jill C. Milne, Ph.D., Chief Executive Officer, will present a corporate overview and provide information on its lead program QLS-215, which is in preclinical development for the treatment of hereditary angioedema, at the following upcoming virtual investor conferences:
- Oppenheimer Rare and Orphan Disease Summit. Presentations will be available on-demand on May 21, 2021.
- Jefferies Virtual Healthcare Conference on June 3, 2021 at 9:30am ET.
Webcasts of the events can be accessed from the investors section of www.catabasis.com. Archived replays will be available for 30 days following the event.
About Catabasis
At Catabasis Pharmaceuticals, our mission is to bring hope with life-changing therapies to patients and families. Our lead program, QLS-215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210514005065/en/
Catabasis Contacts:
Investor relations:
Andrea Matthews
[email protected]
Media:
Elizabeth Higgins
[email protected]
Source: Catabasis Pharmaceuticals, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AS Tallinna Vesi will hold an Investor Conference Webinar to introduce the results for the 1st quarter of 2024
- Vantage Drilling International Ltd. Schedules First Quarter 2024 Earnings Release Date and Conference Call
- Medigene AG reports Financial Results and Business Update for Q1 2024
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!